Rapid access to preventive intervention development program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an overview.
Kapetanovic
Izet M
IM
Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Room 2116, Bethesda, MD 20892, USA. kapetani@mail.nih.gov
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D015507:Drugs, Investigational; D006801:Humans; D054547:National Cancer Institute (U.S.) / Q000458:organization & administration*; D009369:Neoplasms / Q000517:prevention & control*; D014481:United States
D000970:Antineoplastic Agents; D015507:Drugs, Investigational